Literature DB >> 21790860

Establishment and characterization of a novel dedifferentiated liposarcoma cell line, NDDLS-1.

Takashi Ariizumi1, Akira Ogose, Hiroyuki Kawashima, Tetsuo Hotta, Guidong Li, Yongjun Xu, Takanori Hirose, Naoto Endo.   

Abstract

We established a dedifferentiated liposarcoma cell line (NDDLS-1) that produces interleukin-6 (IL-6) and granulocyte-colony stimulating factor (G-CSF). The parental tumor showed high leukemoid reactions. The NDDLS-1 cell line was established from a pleural effusion associated with a lung metastasis. Pleomorphic tumor cells arranged in a haphazard growth pattern were seen in xenograft tumors. Numerous inflammatory cells including neutrophils or eosinophils were present throughout the tumor cells. This finding resembled the dedifferentiated area of the parental tumor. The mice bearing NDDLS-1 showed marked leukocytosis. In addition, the NDDLS-1 cells expressed IL-6 and G-CSF at both the mRNA and protein levels, while the NDDLS-1 cells produced near normal levels of tumor necrosis factor alpha (TNF-α). In the cytogenetic analysis, both the parental tumor and the NDDLS-1 cells showed a ring or giant marker chromosomes. The NDDLS-1 cell line demonstrated the amplification and expression of both MDM2 and CDK4 by fluorescence in situ hybridization and immunohistochemical analysis. The NDDLS-1 cell line is consistent with the parental dedifferentiated liposarcoma, and it should therefore be useful for further investigations of human dedifferentiated liposarcomas.
© 2011 The Authors. Pathology International © 2011 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21790860     DOI: 10.1111/j.1440-1827.2011.02683.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

1.  Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas.

Authors:  Takeaki Ishii; Kenichi Kohashi; Kunio Iura; Akira Maekawa; Hirofumi Bekki; Yuichi Yamada; Hidetaka Yamamoto; Kazuki Nabeshima; Hiroyuki Kawashima; Yukihide Iwamoto; Yoshinao Oda
Journal:  Tumour Biol       Date:  2015-10-30

2.  Explant culture of sarcoma patients' tissue.

Authors:  Roman Muff; Sander M Botter; Knut Husmann; Joelle Tchinda; Philomina Selvam; Franziska Seeli-Maduz; Bruno Fuchs
Journal:  Lab Invest       Date:  2016-04-25       Impact factor: 5.662

3.  [Establishment and characterization of a human lung adenocarcinoma cell line, Ch-Huang-1].

Authors:  Bailing Li; Keng Zhong; Lei Jin; Yang Yuan; Dejun Gong; Xiaohong Liu; Shengdong Huang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-05

4.  Novel systemic therapies in advanced liposarcoma: a review of recent clinical trial results.

Authors:  William W Tseng; Neeta Somaiah; Alexander J Lazar; Dina C Lev; Raphael E Pollock
Journal:  Cancers (Basel)       Date:  2013-05-10       Impact factor: 6.639

5.  Real-time polymerase chain reaction analysis of MDM2 and CDK4 expression using total RNA from core-needle biopsies is useful for diagnosing adipocytic tumors.

Authors:  Taro Sasaki; Akira Ogose; Hiroyuki Kawashima; Tetsuo Hotta; Hiroshi Hatano; Takashi Ariizumi; Hajime Umezu; Riuko Ohashi; Tsuyoshi Tohyama; Naohito Tanabe; Naoto Endo
Journal:  BMC Cancer       Date:  2014-06-26       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.